Literature DB >> 29927060

Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.

Kathrin Tan1, Christian Jäger1, Dagmar Schlenzig1, Stephan Schilling1, Mirko Buchholz1, Daniel Ramsbeck1.   

Abstract

Metalloproteinases of the astacin family are drawing ever increasing attention as potential drug targets. However, knowledge regarding inhibitors thereof is limited in most cases. Crucial for the development of metalloprotease inhibitors is high selectivity, to avoid side effects brought about by inhibition of off-target proteases and interference with physiological pathways. In this study we aimed at the design of novel selective inhibitors for the astacin proteinase meprin α. Based on a recently identified tertiary amine scaffold, a series of compounds was synthesized and evaluated. The compounds exhibit reasonable inhibitory activity with high selectivity over other metalloproteases. The isoenzyme meprin β is only slightly inhibited. Hence, the present study revealed a novel class of selective meprin α inhibitors with improved selectivity over known compounds.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  astacin; hydroxamic acid; meprin α; metalloproteinases; tertiary amines

Mesh:

Substances:

Year:  2018        PMID: 29927060     DOI: 10.1002/cmdc.201800300

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  6 in total

1.  Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor.

Authors:  Charles Bayly-Jones; Christopher J Lupton; Claudia Fritz; Hariprasad Venugopal; Daniel Ramsbeck; Michael Wermann; Christian Jäger; Alex de Marco; Stephan Schilling; Dagmar Schlenzig; James C Whisstock
Journal:  Nat Commun       Date:  2022-10-19       Impact factor: 17.694

2.  A Primary Evaluation of Potential Small-Molecule Inhibitors of the Astacin Metalloproteinase Ovastacin, a Novel Drug Target in Female Infertility Treatment.

Authors:  Hagen Körschgen; Christian Jäger; Kathrin Tan; Mirko Buchholz; Walter Stöcker; Daniel Ramsbeck
Journal:  ChemMedChem       Date:  2020-07-02       Impact factor: 3.466

3.  Discovery and Optimization of Selective Inhibitors of Meprin α (Part II).

Authors:  Chao Wang; Juan Diez; Hajeung Park; Timothy P Spicer; Louis D Scampavia; Christoph Becker-Pauly; Gregg B Fields; Dmitriy Minond; Thomas D Bannister
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27

4.  Discovery and Optimization of Selective Inhibitors of Meprin α (Part I).

Authors:  Shurong Hou; Juan Diez; Chao Wang; Christoph Becker-Pauly; Gregg B Fields; Thomas Bannister; Timothy P Spicer; Louis D Scampavia; Dmitriy Minond
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-28

5.  Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold-Hopping Approach.

Authors:  Kathrin Tan; Christian Jäger; Hagen Körschgen; Stefanie Geissler; Dagmar Schlenzig; Mirko Buchholz; Walter Stöcker; Daniel Ramsbeck
Journal:  ChemMedChem       Date:  2020-12-23       Impact factor: 3.466

6.  Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor.

Authors:  Miriam Linnert; Claudia Fritz; Christian Jäger; Dagmar Schlenzig; Daniel Ramsbeck; Martin Kleinschmidt; Michael Wermann; Hans-Ulrich Demuth; Christoph Parthier; Stephan Schilling
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.